SCHEMBL4760023

SCHEMBL4760023

O=C(Nc1ccc(Nc2cc(NCCO)ncn2)cc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.60
ERBB3 P21860 4/20 0.60
MPL P40238 2/20 0.52
PIP4K2A P48426 3/20 0.48
PIP4K2B P78356 3/20 0.48
AURKB Q96GD4 3/20 0.47
IRAK4 Q9NWZ3 1/20 0.47
AURKA O14965 1/20 0.46
JAK3 P52333 1/20 0.46
PTPN1 P18031 1/20 0.46
ABL1 P00519 1/20 0.45
BCR P11274 1/20 0.45
SIRT1 Q96EB6 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4109552 0.88 MPL (0.52) EGFRERBB3MPLPIP4K2APIP4K2B
SCHEMBL2175670 0.84 EGFR (0.68) EGFRERBB3MPLJAK3MEN1
SCHEMBL2173971 0.84 EGFR (0.72) EGFRERBB3JAK3MEN1NPC1
SCHEMBL2177484 0.79 EGFR (0.57) EGFRERBB3ABL1BCRMEN1
SCHEMBL2173891 0.76 EGFR (0.60) EGFRERBB3MPLMEN1KMT2A
SCHEMBL4760021 0.75 EGFR (0.51) EGFRERBB3MPLAURKBIRAK4
SCHEMBL5735264 0.75 CYP1A2 (0.58) EGFRERBB3PIP4K2APIP4K2BAURKA
SCHEMBL2174917 0.75 EGFR (0.64) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL6499835 0.73 EGFR (0.65) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL2175771 0.73 EGFR (0.54) EGFRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1901747-A2 PYRIMIDINE-BASED CDK INHIBITORS FOR TREATING PAIN Ingenium Pharmaceuticals AG (DE) 2008-03-26 EP claimed
WO-2006125616-A2 PYRIMIDINE-BASED CDK INHIBITORS FOR TREATING PAIN INGENIUM PHARMACEUTICALS AG (DE) 2006-11-30 WO claimed
EP-1678147-A1 PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES GPC Biotech AG (DE) 2006-07-12 EP claimed
WO-2005026129-A1 PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES GPC BIOTECH AG (DE) 2005-03-24 WO claimed